Akero Therapeutics Inc. (AKRO): Among The Stocks That Started The Year On A High
We recently compiled a list of the 5 Stocks That Started The Year On A High. In this article, we are going to take a look at ...
Bronstein, Gewirtz & Grossman, LLC Encourages Akero Therapeutics, Inc. (AKRO) Stockholders to Inquire about Securities Investigation
NEW YORK CITY, NY / ACCESS Newswire / February 6, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims ...
Why Akero Therapeutics Inc (AKRO) Is Skyrocketing So Far In 2025
We recently compiled a list of the Why These 15 Healthcare Stocks Are Skyrocketing So Far In 2025. In this article, we are ...
Akero Therapeutics' chief scientific officer sells $1.06 million in stock
Rolph Timothy, the Chief Scientific Officer of Akero Therapeutics Inc . (NASDAQ:AKRO), recently executed a notable share sale ...
Insider Activity Roundup: Friday's Top Buys and Sells in US Stocks
This article summarizes the most significant insider buying and selling activities reported on Friday for US-listed companies ...
Insider Monkey6d
Why Akero Therapeutics Inc (AKRO) Is Skyrocketing So Far In 2025
In this article, we are going to take a look at where Akero Therapeutics Inc (NASDAQ:AKRO) stands against the other healthcare stocks. The healthcare sector is staging a comeback so far in 2025 ...
89bio initiated with an Outperform at Wolfe Research
Wolfe Research initiated coverage of 89bio (ETNB) with an Outperform rating and $15 price target. Considering how low the stock is currently ...
MarketWatch2d
Akero Therapeutics Inc.
Roche Holding AG Akt 0.65% CHF232.25B ...